North Dakota Administrative Code
Title 61 - Pharmacy, Board of
Article 61-04 - Professional Practice
Chapter 61-04-12 - Limited Prescriptive Authority for Opioid Antagonists
Section 61-04-12-01 - Definitions
Current through Supplement No. 394, October, 2024
For purposes of this chapter:
1. "Opioid-related drug overdose" means a condition including extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death resulting from the consumption or use of an opioid or another substance with which an opioid was combined. This would include an overdose that requires medical assistance or a coroner, clinical suspicion for drug overdose (respiratory depression, unconsciousness, altered mental status), and either a urine toxicology screen positive for opiates or negative urine toxicology screen without other conditions to explain the clinical condition.
2. "Patient" means both an individual who is at risk of opioid overdose and a person who is not at risk of opioid overdose but who may be in a position to assist another individual during an overdose who has received patient information.
3. "Patient information" means the information provided to the patient on drug overdose prevention and recognition, opioid antidote dosage and administration, the importance of calling 911, care for the overdose victim after administration of the overdose antidote, and other issues as necessary.
General Authority: NDCC 28-32-02, 43-15-10
Law Implemented: NDCC 23-01-42, 43-15-10(23)